Basel, Switzerland – April 27, 2026 – Herens Midco S.a.r.l. (“Arxada” or the “Company”) has been engaging in negotiations regarding a maturity extension of its debt instruments (the “A&E Transaction”) with an ad hoc group of holders and/or lenders of its senior secured debt (the “Senior AHG”). Discussions have progressed favorably with the Senior AHG, and the Company is pleased to announce that it has signed a Transaction Support Agreement (“TSA”) for the A&E Transaction with the Senior AHG. Certain other holders of senior secured debt are now also engaging with the Company with a view to acceding to the TSA and providing further support for the A&E Transaction. Thereafter, the Company proposes to engage with all remaining holders of the group’s senior secured notes and lenders of its senior facilities and the holders of its senior unsecured notes with a view to them acceding to the TSA. The Company anticipates that it will be able to make a further announcement giving an update on these discussions shortly.
The Company has its audited financial statements and results ready to publish, with business performance continuing in line with the latest quarterly update and previously issued guidance. Given the ongoing confidential discussions with a wider group of creditors which would otherwise need to be disclosed upon release of the financial statements, the Company will be revising the release date of its FY 2025 financial statements and earnings conference call. The Company anticipates that it will release such financial statements and set an earnings call on or prior to May 29. The Company anticipates using this additional time, which is well within the applicable grace period, to finalize these discussions and to deliver such financial statements in accordance with its principal financing arrangements.
The Company looks forward to updating its investors, lenders and noteholders in due course.
Peter Frauenknecht
Chief Financial Officer
E: cfo.arxada@arxada.com
Emily Johnson
Head of Global Corporate Communications & Investor Relations
E: emily.johnson@arxada.com
Arxada AG
Peter Merian-Strasse 80
CH - 4052 Basel
✆ +41 61 563 8000
Arxada is a global leader in innovative solutions that protect our world. Our groundbreaking technologies, in-depth regulatory know-how, manufacturing and process development help our customers to safeguard nutrition, health and infrastructure efficiently through chemistry and microbiology that enhance sustainability. We offer a broad portfolio of ingredients and services for multiple end-markets that include Human Health & Nutrition, Home & Personal Care, Professional Hygiene, Paints & Coatings and Wood Protection. With customers in more than 100 countries, the company achieved sales of CHF 2billion in 2024. Headquartered in Basel (Switzerland), Arxada employs 3,200 associates across 24 production sites and 14 R&D centers, all committed to our customers’ success.
To learn more about Arxada visit our website arxada.com and Arxada on LinkedIn
This announcement contains forward-looking statements. These statements include, but are not limited to, statements regarding the anticipated timing of future announcements and the publication of our FY 2025 financial statements. Forward-looking statements are based on our current expectations and assumptions and are subject to risks and uncertainties, many of which are outside our control, that could cause actual results or outcomes to differ materially from those expressed or implied in those statements. No assurance can be given that the matters described in these forward-looking statements will occur as described or at all. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.